Clinical Trial Update: Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil [Phase 4]

View source ↗

Summary

Phase 4 study assessing the immune response to an HPV vaccine in HIV-1–infected individuals in Brazil has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Human Papillomavirus Infection

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: University of Sao Paulo | Conditions: Infection | Phase 4 | Status: COMPLETED